McMeekin S - Search Results

1

Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.

Srivastava A, Babu A, Filant J, Moxley KM, Ruskin R, Dhanasekaran D, Sood AK, McMeekin S, Ramesh R. Srivastava A, et al. Among authors: mcmeekin s. J Biomed Nanotechnol. 2016 Jun;12(6):1159-73. doi: 10.1166/jbn.2016.2205. J Biomed Nanotechnol. 2016. PMID: 27319211 Review.

2

Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment.

Srivastava A, Filant J, Moxley KM, Sood A, McMeekin S, Ramesh R. Srivastava A, et al. Among authors: mcmeekin s. Curr Gene Ther. 2015;15(2):182-92. doi: 10.2174/1566523214666141224100612. Curr Gene Ther. 2015. PMID: 25537774 Review.

3

MICU1 drives glycolysis and chemoresistance in ovarian cancer.

Chakraborty PK, Mustafi SB, Xiong X, Dwivedi SKD, Nesin V, Saha S, Zhang M, Dhanasekaran D, Jayaraman M, Mannel R, Moore K, McMeekin S, Yang D, Zuna R, Ding K, Tsiokas L, Bhattacharya R, Mukherjee P. Chakraborty PK, et al. Among authors: mcmeekin s. Nat Commun. 2017 May 22;8:14634. doi: 10.1038/ncomms14634. Nat Commun. 2017. PMID: 28530221 Free PMC article.

4

Role of cystathionine beta synthase in lipid metabolism in ovarian cancer.

Chakraborty PK, Xiong X, Mustafi SB, Saha S, Dhanasekaran D, Mandal NA, McMeekin S, Bhattacharya R, Mukherjee P. Chakraborty PK, et al. Among authors: mcmeekin s. Oncotarget. 2015 Nov 10;6(35):37367-84. doi: 10.18632/oncotarget.5424. Oncotarget. 2015. PMID: 26452259 Free PMC article.

5

Characteristics of 10-year survivors of high-grade serous ovarian carcinoma.

Dao F, Schlappe BA, Tseng J, Lester J, Nick AM, Lutgendorf SK, McMeekin S, Coleman RL, Moore KN, Karlan BY, Sood AK, Levine DA. Dao F, et al. Among authors: mcmeekin s. Gynecol Oncol. 2016 May;141(2):260-263. doi: 10.1016/j.ygyno.2016.03.010. Epub 2016 Mar 11. Gynecol Oncol. 2016. PMID: 26968641 Free PMC article.

6

Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles.

Xiong X, Arvizo RR, Saha S, Robertson DJ, McMeekin S, Bhattacharya R, Mukherjee P. Xiong X, et al. Among authors: mcmeekin s. Oncotarget. 2014 Aug 15;5(15):6453-65. doi: 10.18632/oncotarget.2203. Oncotarget. 2014. PMID: 25071019 Free PMC article.

7

Role of TGF-β signaling in uterine carcinosarcoma.

Dwivedi SK, McMeekin SD, Slaughter K, Bhattacharya R. Dwivedi SK, et al. Oncotarget. 2015 Jun 10;6(16):14646-55. doi: 10.18632/oncotarget.3711. Oncotarget. 2015. PMID: 25918253 Free PMC article.

8

Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary.

Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, McMeekin S, Bloss LP, DiSaia PJ. Bloss JD, et al. Among authors: mcmeekin s. Gynecol Oncol. 1993 Sep;50(3):347-51. doi: 10.1006/gyno.1993.1223. Gynecol Oncol. 1993. PMID: 8406199

9

Quantitative measurement of adiposity using CT images to predict the benefit of bevacizumab-based chemotherapy in epithelial ovarian cancer patients.

Wang Y, Thai T, Moore K, Ding K, McMeekin S, Liu H, Zheng B. Wang Y, et al. Among authors: mcmeekin s. Oncol Lett. 2016 Jul;12(1):680-686. doi: 10.3892/ol.2016.4648. Epub 2016 May 31. Oncol Lett. 2016. PMID: 27347200 Free PMC article.

10

Early prediction of clinical benefit of treating ovarian cancer using quantitative CT image feature analysis.

Qiu Y, Tan M, McMeekin S, Thai T, Ding K, Moore K, Liu H, Zheng B. Qiu Y, et al. Among authors: mcmeekin s. Acta Radiol. 2016 Sep;57(9):1149-55. doi: 10.1177/0284185115620947. Epub 2015 Dec 11. Acta Radiol. 2016. PMID: 26663390 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page